Effect of hysterectomy on the risk of ovarian cancer: A South Korean national cohort study Authors: Jin-Sung Yuk, Sang-Hee Yoon, Bella Stevanny, Bella Stevanny, Mena Abdalla, Mena Abdalla Published: 2026 ABSTRACT BackgroundHysterectomy is a common gynecological surgery, but its long-term impact on ovarian cancer risk remains unclear, particularly in Asian populations.ObjectiveTo evaluate the association between hysterectomy (with or without concomitant adnexal surgery) and the risk of ovarian cancer in South Korean women.MethodsWe conducted a retrospective cohort study using the Korean National Health Insurance Service (NHIS) database (2002–2020). After 1:1 propensity score matching, 13,059 women who underwent hysterectomy for benign indications (aged 40–59) were compared with 13,059 women without hysterectomy. The primary outcome was incident ovarian cancer, defined by three or more medical visits with a C56.xx diagnosis code. Cox proportional hazards models were used to estimate hazard ratios (HRs) for ovarian cancer, adjusting for demographic and clinical confounders.ResultsOver a median follow-up of 11.5 years, ovarian cancer incidence was 18 per 100,000 person-years in the hysterectomy group and 13 per 100,000 person-years in the non-hysterectomy group. Hysterectomy was associated with an imprecise estimate of ovarian cancer risk (HR 1.42, 95% CI 0.79–2.56), compatible with both a clinically meaningful decrease and increase in risk; therefore, the findings are inconclusive. There were no statistically significant differences between the two groups across various decades of life, including females below or above 50 years of age.ConclusionsThis study found no statistically significant association between hysterectomy and ovarian cancer risk, but the wide confidence intervals and limited number of events indicate that the findings remain inconclusive. 1. Introduction Uterus excision or hysterectomy is a common surgical procedure used to treat gynecological morbidities such as abnormal bleeding, uterine fibroids, adenomyosis, and uterine prolapse in women typically impending or after menopause [1]. Although hysterectomy is a prevalent non-obstetric surgical procedure performed on women globally [2], the prevalence of hysterectomy varies between countries, with a gradual decrease observed in high-income countries and an increase observed in low and middle-income countries [1,3]. Many high-income countries report a decrease in prevalence of hysterectomy with rates ranging from 173/100,000 women in Denmark to 510/100,000 in the United States over time due to advances in alternative interventions [1]. Besides, there have been recent reports of an increase in hysterectomy among women from several regions of India [4]. According to the 2015−16 National Family Health Survey in India, almost 1 in 10 women had undergone hysterectomy by the age of 50, ranging up to 1 in 5 in the states of Andhra Pradesh and Telangana [5]. Hysterectomy affords prompt alleviation from the specific medical manifestation such as excessive bleeding and pelvic pain, but it has been ascertained to entail a multitude of enduring health ramifications [6,7]. A recent systematic review including 29 studies on hysterectomy with and without oophorectomy reported an association between hysterectomy and several chronic conditions, including increased risks of cardiovascular events, depression, metabolic disorders, and dementia [8]. Thus, the widespread use of hysterectomy represents an important issue for women’s health over the life course. Hysterectomy protects against cervical and uterine cancers, both of which affect the uterus. Premenopausal hysterectomy, even with ovarian conservation, has been consistently associated with impaired ovarian function [9], likely due to disruption of the utero-ovarian blood supply and altered ovarian perfusion [10–12]. Reduced ovarian blood flow and lower levels of ovarian sex steroids have been observed after hysterectomy [13–15], and several cohort studies have reported almost a two-fold increase in the risk of ovarian failure and an earlier onset of menopause among women who undergo hysterectomy with ovarian preservation [10]. These changes suggest that hysterectomy may decrease cumulative lifetime ovulatory cycles, which in turn could reduce ovarian cancer risk according to the incessant ovulation hypothesis. Conversely, several biological mechanisms support the possibility of a null or even increased risk after simple hysterectomy. Simple hysterectomy leaves the fallopian tubes in situ, and accumulating pathologic and epidemiologic evidence indicates that many high-grade serous ovarian, fallopian tube, and primary peritoneal carcinomas arise from the distal fallopian tube epithelium rather than the ovarian surface itself [16,17]. Therefore, unlike salpingectomy or salpingo-oophorectomy, simple hysterectomy does not remove the presumed primary site of origin for these tumors. In addition, hysterectomy-induced earlier menopause may lead to prolonged use of estrogen-only menopausal hormone therapy (MHT) in women without a uterus, and estrogen-only MHT has been associated with an increased risk of ovarian cancer in observational studies [18]. These competing mechanisms suggest that the net effect of hysterectomy on ovarian cancer risk is biologically uncertain and could plausibly range from risk reduction to no effect or even risk increase. Most epidemiologic studies on the association between hysterectomy and ovarian cancer risk have been conducted in Western populations, and their findings have been heterogeneous, with earlier studies generally suggesting a protective association and more recent analyses reporting weaker or even positive associations [19–21]. Data from Asian populations remain limited, and the overall direction and magnitude of the association between hysterectomy and ovarian cancer risk in these settings are still unclear. Given the high prevalence of hysterectomy and the emerging recognition of fallopian tube–origin high-grade serous carcinogenesis, clarifying the long-term ovarian cancer risk after simple hysterectomy in diverse racial and healthcare contexts is of considerable clinical importance. In this context, we aimed to evaluate the association between simple hysterectomy, with or without bilateral salpingo-oophorectomy, and the risk of ovarian cancer in a large, nationally representative cohort of Korean women. Rather than presuming a strictly protective effect, our study was designed to empirically assess whether hysterectomy is associated with a decreased, unchanged, or increased risk of ovarian cancer in this population. 2. Materials and methods 2.1. Study design and database NHIS is a single-payer health care system that provides mandatory coverage to most residents of South Korea [22]. The NHIS database serves as a valuable source of health insurance information, encompassing crucial details such as the insured individuals’ gender, age, medical coverage type, and the codes for their diagnoses, medications, and surgeries [22]. The NHIS also offers comprehensive health screening services to South Korean citizens at no cost, providing valuable measurement data and health history [22]. This population-based retrospective cohort study utilized data from the National Health Insurance and the National Health Checkup, both provided by the NHIS. The study covered the period from January 1, 2002, to December 31, 2020. The study participants were selected based on specific criteria verified by the 2020 edition of the Korea Health Insurance Medical Care Expenses and the International Classification of Diseases 10th revised edition (ICD-10). We accessed the data after receiving IRB approval for research purposes on December 27, 2021. 2.2. Participant selection The subjects were divided into two groups: the hysterectomy group, which included women aged 40–59 years who had their uterus excised for benign reasons between January 1, 2003, and December 1, 2011, and the non-hysterectomy group, which comprised women aged 40–59 years who underwent a health checkup at the NHIS during the same period. A random sample of 25% of these women was selected to fit the capacity of the NHIS analytical server. These participants were excluded from the study. These included women who underwent a health checkup or hysterectomy for benign reasons in 2002. Women with a medical diagnosis of cancer (any Cxx.xx) or benign ovarian disease (D27 (benign neoplasm of the ovary), N83.0 (follicular cyst of the ovary); N83.1 (corpus luteum cyst); N83.2 (other and unspecified ovarian cyst); N80.1 (endometriosis of the ovary); N80.2 (endometriosis of the fallopian tubes), N83.5 (torsion of the ovaries, cervix, and fallopian tubes)) within 365 days of study enrollment were excluded. Propensity score matching with a 1:1 ratio was used to create the comparison groups. This matching method considered several variables such as age, alcohol consumption, physical exercise level, smoking status, hypertension, diabetes mellitus, dyslipidemia, socioeconomic status (SES), body mass index (BMI), parity, age at first menstruation, menopausal status, previous menopausal hormone therapy (MHT) use, residential area, Charlson comorbidity index (CCI) score, uterine fibroids, prior adnexal surgery, and endometriosis. The study followed up with the participants until December 31, 2020. Because this was a retrospective database study with a fixed study population determined by NHIS availability and eligibility criteria, we did not perform a pre-study sample size calculation. 2.3. Outcomes Women with ovarian cancer were defined as those with three or more visits to a healthcare provider with a diagnosis code (C56.xx) for ovarian cancer in the primary or secondary diagnosis. Because the endpoint was defined using ICD-10 C56.xx claims codes, it captures malignant ovarian neoplasms coded as C56 and does not include borderline ovarian tumors typically coded as D39.1 2.4. Confounding variables The following factors were examined in the study: age (in 5-year increments), BMI (using the criteria of the Asia-Pacific perspective) [23], SES (medical aid as medical insurance), smoking, alcohol consumption, and physical activity levels (self-reported measures), living area (urban or rural area), age at first menstruation (<13 years or ≥13 years), parity (0, 1, 2, or ≥3 births), menopausal status (determined through questionnaire responses), MHT use before inclusion (more than six months of tibolone, combined estrogen/progestogen, or estrogen alone before the study participation date), hysterectomy or concomitant adnexal surgery (recorded using surgery codes), diabetes mellitus (E10–E14), hypertension (I10–I15), uterine fibroids (D25), hyperlipidemia (E78), and endometriosis (N80) (determined by having visited a medical institution for the respective conditions two or more times before study participation) and CCI score (calculated from diagnosis codes from one year before the study participation date to the participation date) [24]. Concomitant adnexal surgery was defined using NHIS procedure codes indicating salpingectomy and/or oophorectomy performed at the time of hysterectomy. Because laterality is not reliably captured in the NHIS procedure codes available for this study, we could not distinguish unilateral from bilateral salpingectomy/oophorectomy. 2.5. Statistics All statistical analyses were performed using R (version 3.5.1; The R Foundation for Statistical Computing, Vienna, Austria). A two-tailed significance level of p < 0.05 was set throughout. For baseline comparisons before matching, categorical variables were assessed using Pearson’s chi-squared or Fisher’s exact tests, and continuous variables were compared using Student’s t-test and the Wilcoxon rank sum test as appropriate. After propensity score matching, categorical variables were analyzed with the Cochran–Mantel–Haenszel test. Continuous variables were compared using the paired t-test and, given that the Anderson–Darling normality test indicated significant departures from normality for all variables (all p-values < 0.001), we relied primarily on the nonparametric Wilcoxon signed-rank test to ensure statistical validity. Covariate balance was evaluated using standardized mean differences. To assess the effect of hysterectomy on ovarian cancer risk, stratified Cox regression analyses were performed, with the Schoenfeld residual test applied to check the proportional hazards assumption. For censoring, we used the earliest among death or last healthcare visit. List-wise deletion was used for missing data during matching. As a sensitivity analysis, we repeated Cox regression exclusively in women with a CCI score of 0. To address potential residual covariate imbalance after propensity score matching (particularly for age), we additionally fitted a multivariable Cox proportional hazards model in the matched cohort adjusting for all baseline covariates included in the propensity score model. All analyses were conducted between July 2022 and January 2023. 2.6. Ethics This study was approved by the Institutional Review Board of Inje University Sanggye Paik Hospital (approval number: SGPAIK 2021-12-005). As these data are public and nonpersonally identifiable, the Institutional Review Board of Inje University Sanggye Paik Hospital IRB waived informed consent. The NHIS carefully anonymized the raw data and performed data analysis within its secure closed server, following its personal protection policy. To maintain confidentiality, unauthorized access to raw data was prevented by restricting data export solely to research outcome analysis. This measure ensured that only authorized individuals could access data and maintained confidentiality and integrity. Informed consent was not required for this study, in accordance with the Bioethics and Safety Act of South Korea. All methods were performed in accordance with the relevant guidelines and regulations. 3. Results We identified 4,024,564 women who underwent hysterectomy or national health examinations between 2003 and 2011. Of these, 1,006,141 (one-fourth) were randomly selected. After propensity score matching, 13,059 women were allocated to the hysterectomy or non-hysterectomy group (Fig 1). The Anderson–Darling normality test applied to continuous covariates in the matched sample uniformly yielded p-values < 0.001, indicating non-normal distributions; therefore, we used the Wilcoxon signed-rank test for group comparisons. Covariate balance was confirmed, with all standardized mean differences (SMDs) below 0.2 (Table 1). 10.1371/journal.pone.0348127.t001Table 1Characteristics of the hysterectomy and non-hysterectomy groups among the subjects in this study (after propensity matching)).Non-HysterectomyHysterectomyTotalP-valueStandardized mean differenceMissing, %Number of women13,05913,05926,118Follow-up period (years)11.4 [10.1-13.5]11.5 [10-13.3]11.5 [10-13.4]0.890.0100Median age (years)48 [44-50]47 [45-50]47 [45-50]0.3970.0580Age at inclusion (years)<0.0010.1740 40~443,350 (25.7)3,051 (23.4)6,401 (24.5) 45~495,274 (40.4)6,325 (48.4)11,599 (44.4) 50~553,544 (27.1)3,075 (23.5)6,619 (25.3) 55~60891 (6.8)608 (4.7)1,499 (5.7)Year at inclusion<0.0010.0410 2003~20051,407 (10.8)1,505 (11.5)2,912 (11.1) 2006~20084,551 (34.8)4,313 (33)8,864 (33.9) 2009~20117,101 (54.4)7,241 (55.4)14,342 (54.9)Median BMI (kg/m2)23.6 [21.7-25.8]23.6 [21.8-25.8]23.6 [21.8-25.8]0.6850.0010BMI (kg/m2)<0.0010.0410 <18.5238 (1.8)194 (1.5)432 (1.7) 18.5-22.95,102 (39.1)5,220 (40)10,322 (39.5) 23-24.93,276 (25.1)3,368 (25.8)6,644 (25.4) 25-29.93,866 (29.6)3,747 (28.7)7,613 (29.1) ≥30577 (4.4)530 (4.1)1,107 (4.2)Low SES47 (0.4)64 (0.5)111 (0.4)0.090.0200Rural area9,317 (71.3)9,372 (71.8)18,689 (71.6)0.2750.0090CCI0.1280.0190 010,585 (81.1)10,643 (81.5)21,228 (81.3) 12,030 (15.5)1,949 (14.9)3,979 (15.2) ≥2444 (3.4)467 (3.6)911 (3.5)Parity0.0280.0270 01,890 (14.5)1,919 (14.7)3,809 (14.6) 11,687 (12.9)1,585 (12.1)3,272 (12.5) 28,738 (66.9)8,846 (67.7)17,584 (67.3) ≥3744 (5.7)709 (5.4)1,453 (5.6)Age over 13 at menarche (years)10,330 (79.1)10,267 (78.6)20,597 (78.9)0.1690.0120Menopause before inclusion1,992 (15.3)1,869 (14.3)3,861 (14.8)<0.0010.0270Smoking0.0230.0300 Never12,216 (93.5)12,307 (94.2)24,523 (93.9) Past241 (1.8)205 (1.6)446 (1.7) Current602 (4.6)547 (4.2)1,149 (4.4)Alcohol (per week)<0.0010.0630 None8,975 (68.7)9,196 (70.4)18,171 (69.6) ~2/week3,843 (29.4)3,569 (27.3)7,412 (28.4) 3~6/week154 (1.2)221 (1.7)375 (1.4) Daily87 (0.7)73 (0.6)160 (0.6)Physical exercise (per week)0.3040.0190 None8,357 (64)8,419 (64.5)16,776 (64.2) 1~22,576 (19.7)2,499 (19.1)5,075 (19.4) 3~41,268 (9.7)1,288 (9.9)2,556 (9.8) 5~6416 (3.2)394 (3)810 (3.1) Daily442 (3.4)459 (3.5)901 (3.4)DM before inclusion1,352 (10.4)1,291 (9.9)2,643 (10.1)0.2120.0150Hypertension before inclusion2,497 (19.1)2,500 (19.1)4,997 (19.1)0.9740.0010Dyslipidemia before inclusion2,093 (16)2,045 (15.7)4,138 (15.8)0.4140.0100MHT before inclusion300 (2.3)168 (1.3)468 (1.8)<0.0010.0760Adnexal surgery before inclusion39 (0.3)11 (0.1)50 (0.2)<0.0010.0490Uterine fibroids before inclusion9,776 (74.9)9,705 (74.3)19,481 (74.6)<0.0010.0120Endometriosis before inclusion2,139 (16.4)2,205 (16.9)4,344 (16.6)<0.0010.0140DM, diabetes mellitus; CCI, Charlson comorbidity index; MHT, menopausal hormone therapy; SES, socioeconomic status.The data is presented as either a number and percentage, or as a median with the interquartile range. Characteristics of the hysterectomy and non-hysterectomy groups among the subjects in this study (after propensity matching)). DM, diabetes mellitus; CCI, Charlson comorbidity index; MHT, menopausal hormone therapy; SES, socioeconomic status. The data is presented as either a number and percentage, or as a median with the interquartile range. Flowchart showing the process of selecting hysterectomy and non-hysterectomy groups using 2002-2020 Korean National Health Insurance data. Most of the participants were in their late 40s (44.4%). They had a median age of 47 [45–50] years and a median follow-up of 11.5 [10–13.4] years (Table 1, S1 Table). The incidence of ovarian cancer was 18 cases per 100,000 person-years in the hysterectomy group and 13 cases per 100,000 person-years in the non-hysterectomy group (p = 0.312). These findings were further supported by a stratified log-rank test, which did not reveal any significant difference in the risk of ovarian cancer between the two groups (p = 0.2). A Kaplan–Meier plot of the incidence of ovarian cancer in the two groups is shown in Fig 2. The near-overlapping curves should be interpreted as reflecting limited event information and imprecision rather than evidence of no effect. Kaplan-Meier plots of ovarian cancer incidence in the hysterectomy and non-hysterectomy groups (stratified log-rank test p-value = 0.2). HTT, hysterectomy. In our stratified Cox proportional analysis assessing the risk of ovarian cancer, the hysterectomy and non-hysterectomy groups exhibited comparable risks of developing ovarian cancer, with a HR of 1.42 and a 95% CI of 0.79 to 2.56 (Table 2). The wide confidence interval indicates substantial uncertainty, and the data remain compatible with both risk reduction and risk increase. Subgroup analyses were exploratory and were not used for inference because of sparse events in some strata (e.g., concomitant adnexal surgery subgroup). Therefore, only the primary matched analysis is emphasized in the main Results. The Cox proportional hazards model was used to analyze the relationship between hysterectomy and ovarian cancer incidence based on age strata. Notably, there were no statistically significant differences between the two groups across various decades of life, including women below or above 50 years of age. For instance, the hazard ratio for women in their 40s stood at 1.17 (95% CI 0.54 to 2.52) and for participants entering their fifth decade it was 1.14 (CI 0.41 to 3.15) respectively. The entire dataset is presented in S2 Table. 10.1371/journal.pone.0348127.t002Table 2Risk of ovarian cancer in women who had a hysterectomy using Cox proportional hazards analysis.Ovarian cancer cases per 100,000 person-yearsHR (95% CI)HR (95% CI) aP-valueNon-hysterectomy20/154,403 (13)1Hysterectomy28/154,109 (18)1.42 (0.79-2.56)0.241CI, confidence interval; HR, hazard ratio.aBecause propensity score matching was performed, hazard ratios were not adjusted for additional confounders. Risk of ovarian cancer in women who had a hysterectomy using Cox proportional hazards analysis. CI, confidence interval; HR, hazard ratio. aBecause propensity score matching was performed, hazard ratios were not adjusted for additional confounders. Regarding Table 1, which contains information on various patient characteristics, S3 Table presents additional specifics on ovarian cancer incidence rates. To ensure thoroughness, we also conducted a sensitivity analysis focusing specifically on patients who had zero CCI entries, that is, those likely harboring fewer comorbid illnesses than others suffering from chronic conditions in the general population. Because age remained the largest residual imbalance after matching (SMD 0.174), we performed a multivariable Cox regression in the matched cohort additionally adjusting for all baseline covariates (including age). The adjusted hazard ratios remained not statistically significant: hysterectomy (with/without concomitant adnexal surgery) HR 1.22 (95% CI 0.56–2.68; P = 0.621), hysterectomy without concomitant adnexal surgery HR 1.16 (0.49–2.73; P = 0.732), and hysterectomy with concomitant adnexal surgery HR 1.66 (0.17–15.79; P = 0.659). Our reanalysis revealed consistent findings whereby hysterectomy’s presence or absence does not appreciably modify ovarian cancer incidence rate among these low complexity individuals either (HR 1.53, 95% CI 0.80–2.94). Moreover, the primary conclusion of this study was true regardless of whether the patients were severely unwell due to other health issues. 4. Discussion Using national population-based cohort data, this study did not find a statistically significant association between hysterectomy and ovarian cancer risk among middle-aged and older women in Korea (HR 1.42, 95% CI 0.79–2.56), but the wide confidence intervals indicate considerable uncertainty regarding the true magnitude and even the direction of the association. Although the association did not reach statistical significance, the point estimate (HR 1.42) suggests a possible increase in ovarian cancer risk after hysterectomy. If this estimate reflected the true effect, it would be clinically important. However, the wide 95% confidence interval (0.79–2.56) indicates that our data are also compatible with a modest risk reduction and with a substantially larger risk increase. Given the limited number of ovarian cancer events in our cohort, our study cannot reliably distinguish among these possibilities and therefore cannot exclude a clinically meaningful increase in risk. There were no statistically significant differences between the two groups across various decades of life, including females below or above 50 years of age. Comprehensive studies have been conducted on the association between ovarian cancer and various gynecologic surgeries, including hysterectomy, salpingectomy, tubal ligation, oophorectomy, and salpingo-oophorectomy [19,25]. Up to now, the surgical removal of fallopian tubes and ovaries has been found to be inversely associated with ovarian cancer. Several studies have also suggested that high-grade serous ovarian, fallopian tube, and primary peritoneal carcinomas are comprised of cells that resemble the fallopian tube epithelium [16]. Based on these findings, the tubal hypothesis, which suggests that high-grade serous cancers could originate in the fallopian tube, was introduced in 2010 [17]. The potential paradigm shift in the comprehension of ovarian cancer is reinforced by epidemiological data indicating that the occlusion or removal of the fallopian tubes protects against subsequent ovarian cancer development [26,27]. Hysterectomy as well as salpingectomy may alter ovarian cancer risk by protecting the ovary from ascending carcinogens. In addition, the impact of premenopausal hysterectomy on ovarian function is associated with disrupted utero-ovarian artery blood flow and reduced sex steroids, potentially leading to premature ovarian failure [9]. Hysterectomy alone increases ovarian failure risk by nearly 2-fold and causes earlier menopause [10]. This diminished ovarian function could potentially reduce the risk of ovarian cancer by decreasing the frequency of ovulatory cycles. Repeated exposure of the ovaries and tubes to the physical and hormonal effects of ovulation (incessant ovulation) is considered one of the most frequently mentioned theories explaining the development of ovarian cancer [28]. To our knowledge, there are three meta-analyses evaluating the association between hysterectomy and ovarian cancer risk [19–21]. The former meta-analysis included 24 observational studies conducted in 2012, and the results showed that hysterectomy is associated with a decrease in the risk of ovarian cancer [19]. The majority of papers included in this meta-analysis were case-control studies, and subgroup analysis was performed on both simple hysterectomy and hysterectomy with unilateral oophorectomy. The summary relative risk (RR) for women with vs. without hysterectomy was 0.74 (95% CI: 0.65–0.84). Simple hysterectomy and hysterectomy with unilateral oophorectomy were associated with a similar decrease in risk (summary relative risk: 0.62, 95% CI: 0.49–0.79 and 0.60, 95% CI:0.47–0.78, respectively). The latter meta-analysis including 20 observational study was conducted in 2013 [20]. The overall relative risk estimate was 0.81 (95% CI 0.72–0.92) suggesting hysterectomy decreases the risk of ovarian cancer. However, significant heterogeneity was observed (I2 = 74%). The authors assessed the effects of possible sources of heterogeneity, including study design, country, response rate in controls, prevalence of hysterectomy, and median year of diagnosis (pre- versus post-2000) using subgroup analyses and multivariate meta-regression models. The largest difference was observed for median year of diagnosis with a pooled relative risk of 0.70 (95% CI: 0.65–0.76) for studies with a median year of diagnosis pre-2000, versus 1.18 (95% CI: 1.06–1.31) post-2000. The results showed a temporal shift in the association between hysterectomy and the risk of ovarian cancer. Specifically, studies in which most women were diagnosed before 2000 found that hysterectomy was associated with a lower risk of ovarian cancer, whereas studies in which the majority of women were diagnosed after 2000 showed a positive association. The most recent meta-analysis was conducted to investigate the long-term outcomes, such as cardiovascular events, metabolic disorders, cancer, depression, and dementia, of hysterectomy with bilateral salpingo-oophorectomy (BSO) [21]. To assess the risk of ovarian cancer among these various outcomes in the meta-analysis, five studies published after 2009 were included [16,25,29–31]. Three studies evaluated the association of hysterectomy with BSO and ovarian cancer risk, including women who had undergone hysterectomy as the reference group [16,29,31]. This approach allowed them to examine the risks associated with elective BSO but limited their ability to separately evaluate the relative risks associated with simple hysterectomy. Conversely, the other two studies investigated the associations of both simple hysterectomy and hysterectomy with BSO in connection to ovarian cancer risk, in comparison to no surgery [25,30]. Associations with simple hysterectomy are plausible due to the potential of the procedure to impair ovarian circulation [32,33]. The reduction in ovarian cancer risk was observed in this meta-analysis of women with previous hysterectomy with BSO on benign indication (HR: 0.11, 95% CI: 0.09–0.15). In detail, hysterectomy with BSO compared to hysterectomy alone or no surgery was associated with substantial reductions in ovarian cancer risk (HR: 0.14, 95% CI: 0.09–0.20 and 0.09, 95% CI: 0.06–0.14, respectively). Contrary to most previous studies, our analysis of ovarian cancer risk related to hysterectomy, using non-surgical controls as a reference group, did not show a significant reduction in ovarian cancer. Several plausible explanations may account for this finding. First, our findings align with the ‘temporal shift’ observed in a 2013 meta-analysis, which reported protective effects (pooled RR 0.70) in pre-2000 studies but increased risk (RR 1.18) in post-2000 studies. This pattern may reflect improved diagnostic specificity in distinguishing ovarian cancer. Second, this discrepancy reflects indication bias: women requiring hysterectomy often have underlying conditions such as endometriosis or adenomyosis, both of which are recognized risk factors for ovarian cancer [34], but these factors may not be fully captured by claims-based propensity score matching. Third, our study participants were women aged 40–59 years with a median age of 47 [45–50] years at hysterectomy and a median follow-up of 11.5 [10–13.4] years. Notably, prior analyses have shown that hysterectomies performed closer to the date of diagnosis show no association with ovarian cancer risk, whereas those performed ≥20 years prior are associated with a 30% risk reduction (RR 0.71, 95% CI 0.55–0.90) [20]. Thus, our relatively short post-hysterectomy follow-up may have limited our ability to detect protective effects. Finally, the potential explanation for our findings pertains to the use of menopausal hormone therapy (MHT) in women experiencing menopausal symptoms following hysterectomy. Hysterectomy could potentially induce premature menopause, resulting in a higher probability of estrogen-only hormone replacement therapy being prescribed for extended durations among women undergoing hysterectomy. Furthermore, women who have undergone hysterectomy are predominantly prescribed estrogen without progestin, and estrogen-only MHT has been associated with an increased risk of ovarian cancer [18]. The adoption of postoperative estrogen-only MHT might have counterbalanced the reduction in ovarian cancer risk associated with hysterectomy. This study has several notable strengths. First, it utilizes a large, nationally representative cohort drawn from the comprehensive Korean National Health Insurance Service database, ensuring broad generalizability to South Korean women. The dataset’s high quality and longitudinal design, featuring a substantial sample size and extended follow-up, enhance statistical power and enable robust outcome assessment. Confounding factors were rigorously controlled through strict inclusion and exclusion criteria and detailed propensity score matching across a wide range of demographic and clinical variables, with balance confirmed by standardized mean differences (all SMDs < 0.2). Finally, most studies on this topic have been conducted in Western countries, including the USA, Canada, Denmark, Sweden, the Netherlands, and Finland. In contrast, our study pioneered research in Asian populations. Nonetheless, some inherent limitations merit acknowledgment. The most important limitation of this study is the limited number of ovarian cancer events, which resulted in wide confidence intervals and low statistical power. Using Schoenfeld’s method for Cox models (two-sided α = 0.05), ~ 247 events would be required for 80% power to detect HR = 0.7 and ~456 events for HR = 1.3; with only 48 events, power is ~ 23% and ~15%, respectively, and the study is only powered for very large effects (approximately HR < 0.45 or >2.24). In particular, the study was severely underpowered to detect anything but a very large effect size, which fundamentally limits the conclusiveness of our findings and means that modest increases or decreases in risk cannot be ruled out. Exploratory subgroup estimates were unstable due to sparse outcome events in some strata (e.g., concomitant adnexal surgery subgroup), and therefore were not emphasized for inference. In addition, outcome misclassification is possible because ovarian cancer was ascertained from claims data and we did not link our analytic dataset directly to the Korean Central Cancer Registry (KCCR). However, a Korean validation study using a KCCR–NHIS linked database reported that operational definitions based on NHIS claims showed high sensitivity (>90%) for major cancers when using either primary diagnosis codes or RID registration claims, and that >80% of patients had a < 31-day difference between the registry diagnosis date and the RID-based claims definition [35]. That study also suggested that the accuracy of RID-based definitions improved after the mid-2000s as the RID program became established, which should be considered when interpreting claims-based case definitions across earlier calendar years. We lacked information on individual genetic risk (e.g., BRCA mutations) and family history of ovarian cancer, restricting exploration of high-risk populations. Although we applied propensity score matching using socioeconomic and lifestyle variables from the same screening program, residual confounding related to health-seeking behavior may still remain. As a retrospective cohort analysis, the potential for unmeasured confounding remains, despite comprehensive covariate adjustment. Lastly, our cohort consisted exclusively of Korean women, which – while relevant for Asian populations – may limit direct extrapolation of findings to other ethnic groups. Future prospective studies with ≥20-year follow-up are needed to assess whether protective effects of hysterectomy on ovarian cancer risk emerge only after longer latency periods, as suggested by prior analyses showing risk reduction primarily among women ≥20 years post-hysterectomy [20]. In conclusion, Hysterectomy was associated with an imprecise, statistically non-significant estimate of ovarian cancer risk; due to limited events and wide confidence intervals, the findings are inconclusive. Further research is needed before clinical recommendations regarding hysterectomy for ovarian cancer risk reduction can be confidently made. Supporting information Characteristics of the hysterectomy and non-hysterectomy groups among the subjects in this study (before propensity matching). (DOCX) Exploratory risk of ovarian cancer by age in women who had a hysterectomy using Cox proportional hazards analysis. (DOCX) Analysis of ovarian cancer incidence per 100,000 person-years in women with and without hysterectomy using Korean National Health Insurance data from 2002-2020. (DOCX) 16 Oct 2025 -->PONE-D-25-36133-->-->Effect of hysterectomy on the risk of ovarian cancer: A South Korean national cohort study-->-->PLOS ONE Dear Dr. Yoon, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:--> A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Bella Stevanny Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Please note that your Data Availability Statement is currently missing [the repository name and/or the DOI/accession number of each dataset OR a direct link to access each database]. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions -->Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. --> Reviewer #1: Partly Reviewer #2: Yes ********** -->2. Has the statistical analysis been performed appropriately and rigorously? --> Reviewer #1: No Reviewer #2: Yes ********** -->3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.--> Reviewer #1: Yes Reviewer #2: Yes ********** -->5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)--> Reviewer #1: In its current form, the manuscript does not provide a reliable answer to its research question. The conclusions are not supported by the presented analysis due to uncontrolled confounding and profound statistical uncertainty. Therefore, the manuscript is not recommended for publication without a substantial and fundamental re-analysis of the data and a complete revision of its interpretation and conclusions. FIND MORE DETAILS IN THE ATTACHMENT. Reviewer #2: This retrospective cohort study, conducted using the Korean National Health Insurance Service database from 2002 to 2020, examined the association between hysterectomy and the risk of ovarian cancer in South Korean women. The results indicated that hysterectomy did not significantly alter the risk of developing ovarian cancer. Consequently, the authors conclude that clinicians should not recommend hysterectomy solely for the purpose of reducing the risk of ovarian cancer. Overall, the research questions explored in this study have the potential to be significant if repeated in numerous robust studies. They could aid in estimating patient prognosis, optimising management of ovarian cancer, and enhancing outcomes. With that in mind, this reviewer has the following to remark: 1. Introduction The first issue to address is punctuation and citation. The authors begin the introduction section by stating, “Uterus excision or hysterectomy is a common surgical procedure used to treat gynecological morbidities such as abnormal bleeding, uterine fibroids, adenomyosis, and uterine prolapse in women typically impending or after menopause.(1)” This style of in-text citation is maintained almost throughout the paper. It is advisable to place any necessary punctuation following in-text citations, not the other way around. And in PLOS ONE, we usually use square brackets for in-text citation. 2. Materials and Methods In subsection 2.2, the authors detail their use of propensity score matching to control for confounding biases. Additionally, subsection 2.5 states, “We conducted a thorough assessment of the balance of matched individual covariates by examining standardized mean differences and ensuring the normality of continuous variables using the Anderson–Darling normality test.” This is important because it’s always advisable to evaluate match quality by checking if the covariates were balanced between the two groups after matching. Without such an evaluation, it would be difficult to assess the effectiveness of the matching approach. I wonder what the results of the Anderson–Darling normality test were. And how representative was the sample of the population from which it was drawn? Did it accurately reflect the entire population? 3. Discussion 3.1 The authors write, “Most studies on this topic have been conducted in Western countries, such as the USA, Canada, Denmark, Sweden, the Netherlands, and Finland. In contrast, our study pioneered the study in Asian populations.” The above statement could be edited to, “Most studies on this topic have been conducted in Western countries, including the USA, Canada, Denmark, Sweden, the Netherlands, and Finland. In contrast, our study pioneered research in Asian populations.” 3.2 In general, the strengths and limitations sections of the study could benefit from editing to improve coherence and readability. 3.3 At the end of the discussion section, the authors state, “This study demonstrated that hysterectomy was not associated with the risk of ovarian cancer, regardless of age or adnexectomy. However, hysterectomy is associated with negative long-term outcomes compared with keeping the uterus intact, especially in young women. Therefore, we recommend that clinicians not recommend hysterectomy, whether with or without salpingo-oophorectomy, to reduce the future risk of ovarian cancer until more evidence is available.” This statement appears to be a conclusion. However, the next section in the paper is titled “Conclusion,” where the authors note, “Hysterectomy was not associated with a significant change in ovarian cancer risk among Korean women, regardless of age or adnexectomy status. Clinicians should not recommend hysterectomy for ovarian cancer risk reduction in average-risk populations.” If the authors prefer to include a conclusion section, they could omit the last part of the discussion section to avoid repetition. I hope this review is helpful and wish the authors the very best with their research! ********** -->6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.--> Reviewer #1: No Reviewer #2: Yes: Dr. Widad Akreyi ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: New Microsoft Word Document.docx 3 Nov 2025 Reviewer comment Response to Reviewer #1 Comments We thank the reviewer for highlighting both the strengths and methodological challenges of our cohort study. Below, we respond directly and assertively to each major point with supporting evidence from our data and current analytic standards. 1. Propensity Score Matching (PSM), SMD, and Covariate Balance Reviewer comment: PSM yielded residual imbalance in key covariates including age, with SMD reported as 0.174. This is interpreted to indicate the matching failed. Response: Contrary to the assertion that an SMD 0.174 signifies inadequate balance, the established epidemiological and statistical consensus defines an SMD < 0.2 as reflecting acceptable balance between matched cohorts[1, 2]. In our study, all reported SMDs after matching, including the cited value for age, were below this widely recognized threshold, indicating adequate matching and effective minimization of confounding. As detailed in Table 1 and supplementary analyses, residual imbalances were minor and are unlikely to materially influence the primary outcome. Furthermore, sensitivity analyses in subjects with zero comorbidity (CCI = 0) confirm the robustness of our inference, yielding consistent hazard ratios for ovarian cancer. We therefore strongly contend that our matching procedure meets accepted methodological standards and that our results can be interpreted with scientific confidence. 2. Statistical Power (Event Number) and Conclusion Validity Reviewer comment: The low number of ovarian cancer cases leads to wide confidence intervals; the conclusion should be “inconclusive” rather than “no effect.” Response: We acknowledge the limited number of events and the wide confidence intervals in our analysis. However, these event rates reflect the real-world rarity of ovarian cancer, particularly in Asian populations over a median follow-up of 11.5 years. Our cohort of over 26,000 women is among the largest Asian hysterectomy samples published to date. Importantly, the direction of the hazard ratio remained consistent across sensitivity and subgroup analyses. Nevertheless, in response to this criticism, we have explicitly revised our conclusion language to acknowledge the limitations in statistical power and now state that the results are “not statistically significant and inconclusive” regarding an association. Revised manuscript (Discussion part): “In conclusion, hysterectomy was not statistically significantly associated with ovarian cancer risk in Korean women. However, due to limited events and wide confidence intervals, these findings are inconclusive. Further research is needed before clinical recommendations regarding hysterectomy for ovarian cancer risk reduction can be confidently made.” 3. Analytical Interpretation (Absence of Evidence ≠ Evidence of Absence) Reviewer comment: Nonsignificant p-values or confidence intervals should not be over-interpreted as absence of effect. Response: We agree with this methodological principle. Throughout the revised manuscript, all relevant sections now clarify that while our findings are not statistically significant, they do not demonstrate evidence of absence; the true relationship remains uncertain due to sample size and event limitation. Revised manuscript (Abstract part): “Hysterectomy does not appear to significantly alter ovarian cancer risk among Korean women; however, the limited number of ovarian cancer cases and wide confidence intervals result in inconclusive findings. Further studies are needed before establishing clinical recommendations.” Revised manuscript (Discussion part): “In conclusion, hysterectomy was not statistically significantly associated with ovarian cancer risk in Korean women. However, due to limited events and wide confidence intervals, these findings are inconclusive. Further research is needed before clinical recommendations regarding hysterectomy for ovarian cancer risk reduction can be confidently made.” 4. Minor Issues (Tables, Data Sharing Policy) Reviewer comment: Typographical errors in tables; confusion in the statement about data sharing. Response: All typographical errors in the revised tables have been corrected. Regarding data sharing, the National Health Insurance Service of Korea enforces strict privacy regulations that prohibit the disclosure of raw data. This restriction has now been clearly stated in the revised manuscript, in full compliance with NHIS policy. While the methods and acknowledgments sections of the manuscript correctly indicate that data sharing is not permitted, the submission form previously stated otherwise, which may have caused confusion. To resolve this inconsistency, we have removed the phrase “all data are fully available without restriction” from the submission form. 5. Feasibility of Re-analysis Reviewer comment: Further analyses (enhanced matching, IPTW, or covariate adjustments) are requested. Response: We recognize the value of such analyses. However, the official analytic period for the dataset has concluded and the NHIS system now prohibits all further access, as per Korean government guidelines for privacy and IT security. This practical and legal constraint is explicitly stated in the revised manuscript. Response to Reviewer #2 Comments We thank Reviewer #2 for their careful reading, constructive feedback, and positive remarks about the significance and potential of our study. We respond to each point individually below, providing a robust and evidence-based defense for our methods and addressing all editorial and methodological comments. 1. Introduction: Punctuation and In-text Citation Style Reviewer comment: Punctuation should follow, not precede, in-text citations. PLOS ONE requires square brackets for citations. Response: We appreciate the reviewer’s attention to editorial detail. We have systematically revised the manuscript so that all in-text citations now use square brackets, with punctuation placed after the reference, consistent with PLOS ONE guidelines. This improves compliance and readability throughout the introduction and main text. 2. Materials and Methods: PSM, SMD, and Anderson-Darling Test Reviewer comment: The necessity of evaluating match quality is highlighted. Reviewer requests results of the Anderson–Darling normality test and questions the representativeness of the sample. Response: We agree on the importance of formally evaluating the distributional properties of covariates after matching. We performed the Anderson–Darling normality test for all continuous covariates in our matched samples, which uniformly resulted in p-values < 0.001, indicating violations of normality assumptions. In accordance with these results, we applied the Wilcoxon signed-rank test for between-group comparisons of continuous variables rather than parametric approaches, ensuring statistical validity. These procedures and testing outcomes are now explicitly described in the revised Methods and Results sections. Revised manuscript (Methods part): “After propensity score matching, categorical variables were analyzed with the Cochran–Mantel–Haenszel test. Continuous variables were compared using the paired t-test and, given that the Anderson–Darling normality test indicated significant departures from normality for all variables (all p-values < 0.001), we relied primarily on the nonparametric Wilcoxon signed-rank test to ensure statistical validity. Covariate balance was evaluated using standardized mean differences.” Revised manuscript (Results part): “The Anderson–Darling normality test applied to continuous covariates in the matched sample uniformly yielded p-values < 0.001, indicating non-normal distributions; therefore, we used the Wilcoxon signed-rank test for group comparisons. Covariate balance was confirmed, with all standardized mean differences (SMDs) below 0.2 (Table 1).” Regarding representativeness, our cohort was drawn from the comprehensive Korean National Health Insurance Service (NHIS) database, which covers virtually the entire South Korean population. Thus, our sample is highly representative and generalizable to the national demographic. 3. Discussion: Editorial Comments 3.1 Western vs. Asian Studies Wording Reviewer comment: Suggested improvements to the phrasing distinguishing Western and Asian research. Response: We have adopted the reviewer’s proposed revision to enhance clarity. Revised manuscript (Discussion part): “Finally, most studies on this topic have been conducted in Western countries, including the USA, Canada, Denmark, Sweden, the Netherlands, and Finland. In contrast, our study pioneered research in Asian populations.” 3.2 Editing of Strengths and Limitations Reviewer comment: Recommends editing for coherence and readability. Response: We accept this valuable suggestion. The strengths and limitations sections have been thoroughly reviewed and edited to maximize clarity and logical flow, as detailed in the revised Discussion. Revised manuscript (Discussion part): “This study has several notable strengths. First, it utilizes a large, nationally representative cohort drawn from the comprehensive Korean National Health Insurance Service database, ensuring broad generalizability to South Korean women. The dataset’s high quality and longitudinal design, featuring a substantial sample size and extended follow-up, enhance statistical power and enable robust outcome assessment. Confounding factors were rigorously controlled through strict inclusion and exclusion criteria and detailed propensity score matching across a wide range of demographic and clinical variables, with balance confirmed by standardized mean differences (all SMDs < 0.2). Additionally, subgroup and sensitivity analyses further strengthened the internal validity of our findings. Finally, most studies on this topic have been conducted in Western countries, including the USA, Canada, Denmark, Sweden, the Netherlands, and Finland. In contrast, our study pioneered research in Asian populations. Nonetheless, some inherent limitations merit acknowledgment. We lacked information on individual genetic risk (e.g., BRCA mutations) and family history of ovarian cancer, restricting exploration of high-risk populations. As a retrospective cohort analysis, the potential for unmeasured confounding remains, despite comprehensive covariate adjustment. The limited number of ovarian cancer events narrows precision and statistical power for subgroup analyses, necessitating cautious interpretation. Lastly, our cohort consisted exclusively of Korean women, which—while relevant for Asian populations—may limit direct extrapolation of findings to other ethnic groups.” 3.3 Repetition in Discussion and Conclusion Reviewer comment: The end of the Discussion repeats concluding statements, which are then also stated in the Conclusion; suggests omitting redundancy. Response: To avoid unnecessary repetition, the conclusions with overly broad titles have been removed and are now briefly summarized at the end of the Discussion section. In accordance with the reviewers' editorial guidelines, the main conclusions are confined to the Discussion section. Revised manuscript (Discussion part): “In conclusion, hysterectomy was not statistically significantly associated with ovarian cancer risk in Korean women. However, due to limited events and wide confidence intervals, these findings are inconclusive. Further research is needed before clinical recommendations regarding hysterectomy for ovarian cancer risk reduction can be confidently made.” 1. Stuart, E.A., Matching methods for causal inference: A review and a look forward. Stat Sci, 2010. 25(1): p. 1-21. 2. Austin, P.C., Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med, 2009. 28(25): p. 3083-107. Submitted filename: 2025-11-01_Author Response Letter_v1.docx 7 Jan 2026